

We read with interest the Article by Gregory C McDermott and colleagues, which reports an association between high disease activity and the prevalence of rheumatoid arthritis-associated interstitial lung disease (ILD) in patients with early rheumatoid arthritis.1 Their work contributes valuable data to the urgent clinical need for effective screening strategies for rheumatoid arthritis-associated ILD.
Rheumatology
|11th Mar, 2026
|The New England Journal of Medicine
Rheumatology
|11th Mar, 2026
|The New England Journal of Medicine
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet